Literature DB >> 9449873

Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants.

R F Wynn1, M A Cross, C Hatton, A M Will, L S Lashford, T M Dexter, N G Testa.   

Abstract

BACKGROUND: The establishment of donor-derived haemopoiesis in the recipients of allogeneic bone-marrow transplants (BMT) involves extensive proliferation of haemopoietic stem cells. The biological consequences of this replicative stress are ill defined, but any "ageing" effect would carry the risk of an increased frequency of clonal disorders during later life. We compared blood-cell mean telomere lengths in donor/recipient pairs.
METHODS: Mean telomere length was calculated by in-gel hybridisation to leucocyte DNA from 56 normal individuals aged 0-96 years, and from 14 consecutive BMT recipients (aged 2-14 years) plus their respective donors (aged 2-46 years). Engraftment was confirmed by variable numbers of tandem repeats (VNTR) or gender analysis.
FINDINGS: On average, blood-cell telomeres of transplant recipients were 0.4 kb (95% CI -0.2 to -0.6) shorter than those of their respective donors. This degree of telomere loss is equivalent to a median of 15 years' (range 0-40) ageing in the healthy controls.
INTERPRETATION: The kinetics of haemopoietic engraftment impose replicative stress on the haemopoietic stem cells, resulting in a pronounced ageing effect, which may be sufficient to accelerate the onset of clonal haemopoietic disorders usually associated with later life. Monitoring of haemopoietic status in BMT recipients as time since BMT increases will be important. Assessment of transplant protocols under development in terms of their effects on telomere shortening is also indicated.

Entities:  

Mesh:

Year:  1998        PMID: 9449873     DOI: 10.1016/S0140-6736(97)08256-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  40 in total

1.  Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning.

Authors:  Navneet S Majhail; Ruta Brazauskas; J Douglas Rizzo; Ronald M Sobecks; Zhiwei Wang; Mary M Horowitz; Brian Bolwell; John R Wingard; Gerard Socie
Journal:  Blood       Date:  2010-10-06       Impact factor: 22.113

Review 2.  Telomerase and the aging process.

Authors:  Peter J Hornsby
Journal:  Exp Gerontol       Date:  2007-03-30       Impact factor: 4.032

3.  Isolation and therapeutic potential of human haemopoietic stem cells.

Authors:  Andrew D Clark; Heather G Jørgensen; Joanne Mountford; Tessa L Holyoake
Journal:  Cytotechnology       Date:  2003-03       Impact factor: 2.058

4.  Race-Ethnicity, Poverty, Urban Stressors, and Telomere Length in a Detroit Community-based Sample.

Authors:  Arline T Geronimus; Jay A Pearson; Erin Linnenbringer; Amy J Schulz; Angela G Reyes; Elissa S Epel; Jue Lin; Elizabeth H Blackburn
Journal:  J Health Soc Behav       Date:  2015-04-30

Review 5.  Telomeres, atherosclerosis, and the hemothelium: the longer view.

Authors:  Abraham Aviv; Daniel Levy
Journal:  Annu Rev Med       Date:  2011-10-17       Impact factor: 13.739

6.  Quantification of hTERT splice variants in melanoma by SYBR green real-time polymerase chain reaction indicates a negative regulatory role for the beta deletion variant.

Authors:  Lisa F Lincz; Lisa-Maree Mudge; Fiona E Scorgie; Jennette A Sakoff; Christopher S Hamilton; Michael Seldon
Journal:  Neoplasia       Date:  2008-10       Impact factor: 5.715

Review 7.  Aging stem cells, latexin, and longevity.

Authors:  Ying Liang; Gary Van Zant
Journal:  Exp Cell Res       Date:  2008-02-19       Impact factor: 3.905

8.  Dynamics of epigenetic age following hematopoietic stem cell transplantation.

Authors:  Friedrich Stölzel; Mario Brosch; Steve Horvath; Michael Kramer; Christian Thiede; Malte von Bonin; Ole Ammerpohl; Moritz Middeke; Johannes Schetelig; Gerhard Ehninger; Jochen Hampe; Martin Bornhäuser
Journal:  Haematologica       Date:  2017-05-26       Impact factor: 9.941

9.  Invariant natural killer T cells generated from human adult hematopoietic stem-progenitor cells are poly-functional.

Authors:  Wenji Sun; Yi Wang; James E East; Amy S Kimball; Katherine Tkaczuk; Susan Kesmodel; Scott E Strome; Tonya J Webb
Journal:  Cytokine       Date:  2015-01-05       Impact factor: 3.861

Review 10.  Telomere diseases.

Authors:  Rodrigo T Calado; Neal S Young
Journal:  N Engl J Med       Date:  2009-12-10       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.